Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Neurological Disorders and Stroke (NINDS) plans to issue a Notice of Funding Opportunity (NOFO) aimed at supporting research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This upcoming NOFO will focus on fostering new collaborative teams to tackle emerging research challenges in ME/CFS, encouraging investigators with relevant expertise to develop partnerships and innovative project proposals. The funding opportunity will utilize the P20 activity code, with applications not being accepted at the current time but anticipated in the near future. The initiative places a particular emphasis on collaborative studies that combine expertise in post-infectious chronic illnesses alongside ME/CFS research, encouraging interdisciplinary approaches. Potential applicants are advised to begin considering and preparing for submission once the NOFO is officially released. For further inquiries, Vicky Whittemore, Ph.D., at NINDS is the designated contact. This effort reflects NINDS’s commitment to advancing understanding and treatment strategies for ME/CFS through coordinated and exploratory research initiatives.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) focused on the establishment of new collaborative teams to address emergent issues in ME/CFS research. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the P20 activity code. Investigators with expertise and insights into this area of science are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in post-infectious chronic illnesses and ME/CFS will be encouraged, and these investigators should also begin considering applying for this application.
